| Basics |
Medtronic plc
Medtronic PLC is a medical technology company. It is primarily manufactures and sells device-based medical therapies. It operates in Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies and Diabetes segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$122.92B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.87%
|
| Avg Daily Range (30 D): |
$0.80 | 0.84%
|
| Avg Daily Range (90 D): |
$0.74 | 0.80%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.18M |
| Avg Daily Volume (30 D): |
5.22M |
| Avg Daily Volume (90 D): |
5.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
144 |
| Avg Trade Size (Sh.) (30 D): |
69 |
| Avg Trade Size (Sh.) (90 D): |
72 |
| Institutional Trades |
| Total Inst.Trades: |
110,002 |
| Avg Inst. Trade: |
$4.73M |
| Avg Inst. Trade (30 D): |
$14.61M |
| Avg Inst. Trade (90 D): |
$12.19M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
19 |
| Market Closing Trades |
| Avg Closing Trade: |
$45.98M |
| Avg Closing Trade (30 D): |
$116.4M |
| Avg Closing Trade (90 D): |
$103.49M |
| Avg Closing Volume: |
561.22K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$3.64
|
$.81
|
$.83
|
|
Diluted EPS
|
$3.63
|
$.81
|
$.82
|
|
Revenue
|
$ 34.2B
|
$ 8.58B
|
$ 8.93B
|
|
Gross Profit
|
$ 22.33B
|
$ 5.58B
|
$ 5.78B
|
|
Net Income / Loss
|
$ 4.69B
|
$ 1.05B
|
$ 1.06B
|
|
Operating Income / Loss
|
$ 6.12B
|
$ 1.45B
|
$ 1.44B
|
|
Cost of Revenue
|
$ 11.87B
|
$ 3B
|
$ 3.15B
|
|
Net Cash Flow
|
$ -38M
|
$ -945M
|
$ 978M
|
|
PE Ratio
|
26.42
|
|
|
|
|
|
